How Gene-Editing Therapies Are Revolutionizing ...

By Rene Pretorius

June 18, 2025

Summary Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics represents a transformative step in addressing
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Urgent Need for Pediatric Heart Devices
Sugary Drinks Cancer Risk: Women Face Higher Oral Cavity Cancer Threat
Exploring the MASLD CKD Socioeconomic Link
Engineering Resilience: Mastering Pharma Patent Expiration Strategy
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
Advancing Heart Transplantation: The Role of the Lumped Parameter Model
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
Hypertension in Young South African Adults
ACS Management Innovations: Transforming Patient Outcomes in Acute Coronary S...